4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020658
President and CEO sold 5,380 shares at an average $0.38 ($2,044)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-11 | Sale : show line 1 in the form 10b5-1 | −2,731 | $0.37 | $1,010 | 712,692 | D |
| 2023-07-12 | Sale : show line 2 in the form 10b5-1 | −2,649 | $0.39 | $1,033 | 710,043 | D |
| Open-market sales · 5,380 sh · avg $0.38 · $2,044 | ||||||
Loading xslF345X04/form4.xml…